Christopher Wai Kei Lam (Brian Tomlinson)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Venues

Expert opinion on pharmacotherapy

Expert opinion on drug metabolism & toxicology

Cardiovascular drugs and therapy

Journal of lipid and atherosclerosis

Chinese University of Hong Kong Faculty of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese University of Hong Kong Faculty of Medicine Aug 01 2015

Hong Kong

Adjunct Professor :: Medicine & Therapeutics

Chinese University of Hong Kong Faculty of Medicine Jun 01 2003 - Jul 31 2015

China

Professor of Medicine and Therapeutics :: Department of Medicine and Therapeutics

Publications

Weiwei Zeng, Christopher Wai Kei Lam
Options for patients with out-of-control blood pressure: after all avenues have been exhausted. Expert review of cardiovascular therapy (2024)
Christopher Wai Kei Lam, Qian-Yan Wu, Yi-Ming Zhong, Yan-Hong Li
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors. Journal of lipid and atherosclerosis 13 (1) (2023)
Xiaoyu Wang, Xiaoli Chen, Yanfang Wang, Sheng Peng, Jingjiang Pi, Jinnan Yue, Qingshu Meng, Jie Liu, Liang Zheng, Paul Chan, Christopher Wai Kei Lam, Zhongmin Liu, Yuzhen Zhang
The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients. International journal of general medicine 16 (2023)
Christopher Wai Kei Lam, Qian-Yan Wu, Yi-Ming Zhong, Yan-Hong Li
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors. Journal of lipid and atherosclerosis 13 (1) (2023)
Joseph Edgar Blais, Xuxiao Ye, Eric Yuk Fai Wan, William Chi Wai Wong, Ian Chi Kei Ck Wong, Christopher Wai Kei Lam, Esther Wai Yin Chan
Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients. Clinical drug investigation 42 (11) (2022)
Ut-Sam Lao, Chak-Fun Law, Daniel T Baptista-Hon, Christopher Wai Kei Lam
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients. Journal of clinical medicine 11 (18) (2022)
YingLu Wang, Chang Liu, Liping Liu, Xiaoli Chen, Lu Wei, Jie Liu, Sheng Peng, Jingjiang Pi, Qi Zhang, Christopher Wai Kei Lam, Paul Chan, Lin Zhang, Huimin Fan, Liang Zheng, Zhongmin Liu, Yuzhen Zhang
Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese. Clinical interventions in aging 17 (2022)
Sze Wa Chan, Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Pharmaceutical biology 59 (1) (2022)
Weiwei Zeng, Tanya T W Chu, Elaine Y K Chow, Miao Hu, Benny S P Fok, Juliana Chung Ngor Chan, Bryan P Y Yan, Christopher Wai Kei Lam
Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate ® Analyzer and Serum Thromboxane B 2 . Pharmaceutics 14 (10) (2022)
Xiaoli Chen, Jianfei Xu, Wenzhen Bao, Hongda Li, Wenrun Wu, Jiwen Liu, Jingjiang Pi, Christopher Wai Kei Lam, Paul Chan, Cheng-Chao Ruan, Qi Zhang, Lin Zhang, Huimin Fan, Edward Morrisey, Zhongmin Liu, Yuzhen Zhang, Li Lin, Jie Liu, Tao Zhuang
Endothelial Foxp1 Regulates Neointimal Hyperplasia Via Matrix Metalloproteinase-9/Cyclin Dependent Kinase Inhibitor 1B Signal Pathway. Journal of the American Heart Association 11 (15) (2022)
Christopher Wai Kei Lam, Elaine Y K Chow, Paul Chan, Christopher Wai Kei Lam
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert opinion on drug metabolism & toxicology 17 (12) (2022)
Christopher Wai Kei Lam, Yan-Hong Li, Paul Chan
Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert opinion on pharmacotherapy 23 (17) (2022)
Wei-Wei Zeng, Sze Wa Chan, Christopher Wai Kei Lam
Patient preferences for ambulatory blood pressure monitoring devices: Wrist-type or arm-type? PloS one 16 (8) (2021)
Jingqi Zhu, Zhangwei Yang, Xiaoli Chen, Jie Liu, Liang Zheng, Lin Zhang, Jingjiang Pi, Gang Li, Tao Zhuang, Chang Liu, Yinglu Wang, Liping Liu, Lieying Fan, Paul Chan, Christopher Wai Kei Lam, Ying Li, Zhongmin Liu, Yuzhen Zhang
A Stronger Association of Epicardial Fat Volume with Non-Valvular Atrial Fibrillation Than Measures of General Obesity in Chinese Patients Undergoing Computed Tomography Coronary Angiography. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Christopher Wai Kei Lam, Nivritti Gajanan Patil, Manson Fok, Paul Chan, Christopher Wai Kei Lam
The role of sulfonylureas in the treatment of type 2 diabetes. Expert opinion on pharmacotherapy (2021)
Julia K Goodrich, Moriel Singer-Berk, Rachel Son, Abigail Sveden, Jordan Wood, Eleina England, Joanne B Cole, Ben Weisburd, Nick Watts, Lizz Caulkins, Peter Dornbos, Ryan Koesterer, Zachary Zappala, Haichen Zhang, Kristin A Maloney, Andrew W Dahl, Carlos A Aguilar-Salinas, Gil Atzmon, Francisco Barajas-Olmos, Nir Barzilai, John E Blangero, Eric Boerwinkle, Lori L Bonnycastle, Erwin Bottinger, Donald W Bowden, Federico Centeno-Cruz, John C Chambers, Nathalie Chami, Edmund Chan, Juliana Chan, Ching-Yu Cheng, Yoon Shin Cho, Cecilia Contreras-Cubas, Emilio Córdova, Adolfo Correa, Ralph A DeFronzo, Ravindranath Duggirala, Josée Dupuis, Ma Eugenia Garay-Sevilla, Humberto Garcia-Ortiz, Christian Gieger, Benjamin Glaser, Clicerio González-Villalpando, Ma Elena Gonzalez, Niels Grarup, Leif C Groop, Myron Gross, Christopher Haiman, Sohee Han, Craig L Hanis, Torben Hansen, Nancy Heard- Costa, Brian E Henderson, Juan Manuel Malacara Hernandez, Mi Yeong Hwang, Sergio Islas-Andrade, Marit E Jørgensen, Hyun Min Kang, Bong-Jo Kim, Young Jin Kim, Heikki A Koistinen, Jaspal Singh Kooner, Johanna Kuusisto, Soo-Heon Kwak, Markku Laakso, Leslie Lange, Jong Young Lee, Juyoung Lee, Donna M Lehman, Allan Linneberg, Jian-Jun Liu, Ruth J F Loos, Valeriya Lyssenko, Ronald Ching-Wan Ma, Angélica Martínez-Hernández, James B Meigs, Thomas Meitinger, Elvia Mendoza-Caamal, Karen L Mohlke, Andrew D Morris, Alanna C Morrison, Maggie C Y Ng, Peter M Nilssson, Christopher J O'Donnell, Lorena Orozco-Orozco, Colin Neil Alexander Palmer, Kyong-Soo Park, Wendy S Post, Oluf Pedersen, Michael H Preuss, Bruce M Psaty, Alexander P Reiner, Cristina Revilla-Monsalve, Stephen S Rich, Jerome I Rotter, Danish Saleheen, Claudia Schurmann, Xueling S Sim, Robert Sladek, Kerrin S Small, Wing Yee So, Timothy D Spector, Konstantin Strauch, Tim M Strom, E Shyong Tai, Claudia Ha-Ting Tam, Yik Ying Teo, Farook Thameem, Christopher Wai Kei Lam, Russell P Tracy, Tiinamaija Tuomi, Jaakko Tuomilehto, Teresa Tusié-Luna, Rob M van Dam, Ramachandran S Vasan, James G Wilson, Daniel R Witte, Tien-Yin Wong, null null, Noël P Burtt, Noah Zaitlen, Mark I McCarthy, Michael Boehnke, Toni I Pollin, Jason Flannick, Josep Maria Mercader, Anne H O'Donnell-Luria, Samantha Baxter, Jose C Florez, Daniel G MacArthur, Miriam S Udler
Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes. Nature communications 12 (1) (2021)
Christopher Wai Kei Lam, Chen-Hsiu Lin, Paul Chan, Christopher Wai Kei Lam
Personalized medicine in lipid-modifying therapy. Personalized medicine 18 (2) (2021)
Christopher Wai Kei Lam, Nivritti Gajanan Patil, Manson Fok, Christopher Wai Kei Lam
Managing dyslipidemia in patients with Type 2 diabetes. Expert opinion on pharmacotherapy 22 (16) (2021)
Joyce Tik Sze Li, Amy Shuk Man Lam, Christopher Wai Kei Lam, Vivian Wing Yan Lee
May Measurement Month 2017-2019: A Community-Wide Opportunistic Blood Pressure Screening Campaign in Hong Kong. International journal of hypertension 2021 (2021)
Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes. Expert opinion on pharmacotherapy (2021)
Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
Statin Controversies Continued: Response to the Letter from Azemawah et al. Cardiovascular drugs and therapy 34 (6) (2020)
Christopher Wai Kei Lam, Paul Chan, Yuzhen Zhang, Christopher Wai Kei Lam
Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert opinion on pharmacotherapy 21 (17) (2020)
Christopher Wai Kei Lam, Paul Chan, Zhongmin Liu, Christopher Wai Kei Lam
Statin Pharmacology Revisited. Cardiovascular drugs and therapy 34 (2) (2020)
Cassandra N Spracklen, Momoko Horikoshi, Young Jin Kim, Kuang Lin, Fiona Bragg, Sanghoon Moon, Ken Suzuki, Claudia Ha-Ting Tam, Yasuharu Tabara, Soo-Heon Kwak, Fumihiko Takeuchi, Jirong Long, Victor J Y Lim, Jin Fang Chai, Chien-Hsiun Chen, Masahiro Nakatochi, Jie Yao, Hyeok Sun Choi, Apoorva K Iyengar, Hannah J Perrin, Sarah M Brotman, Martijn van de Bunt, Anna L Gloyn, Jennifer E Below, Michael Boehnke, Donald W Bowden, John C Chambers, Anubha Mahajan, Mark I McCarthy, Maggie C Y Ng, Lauren E Petty, Weihua Zhang, Andrew P Morris, Linda S Adair, Masato Akiyama, Zheng Bian, Juliana C N Chan, Li-Ching Chang, Miao-Li Chee, Yii-Der Ida Chen, Yuan-Tsong Chen, Zhengming Chen, Lee-Ming Chuang, Shufa Du, Penny Gordon-Larsen, Myron Gross, Xiuqing Guo, Yu Guo, Sohee Han, Annie-Green Howard, Wei Huang, Yi-Jen Hung, Mi Yeong Hwang, Chii-Min Hwu, Sahoko Ichihara, Masato Isono, Hye-Mi Jang, Guozhi Jiang, Jost Bruno Jonas, Yoichiro Kamatani, Tomohiro Katsuya, Takahisa Kawaguchi, Chiea Chuen Khor, Katsuhiko Kohara, Myung-Shik Lee, Nanette R Lee, Liming Li, Jian-Jun Liu, Andrea O Luk, Jun Lv, Yukinori Okada, Mark A Pereira, Sabanayagam Charumathi, Jinxiu Shi, Dong Mun Shin, Wing Yee So, Atsushi Takahashi, Christopher Wai Kei Lam, Fuu-Jen Tsai, Rob M van Dam, Yong-Bing Xiang, Ken Yamamoto, Toshimasa Yamauchi, Kyungheon Yoon, Canqing Yu, Woon-Puay Koh, Liang Zhang, Quan Long, Michiya Igase, Yoon Shin Cho, Jerome I Rotter, Ya-Xing Wang, Wayne H H Sheu, Mitsuhiro Yokota, Jer-Yuarn Wu, Ching-Yu Cheng, Tien-Yin Wong, Xiao-Ou Shu, Norihiro Kato, Kyong-Soo Park, E-Shyong Tai, Fumihiko Matsuda, Woon-Puay Koh, Ronald Ching-Wan Ma, Shiro Maeda, Iona Y Millwood, Juyoung Lee, Takashi Kadowaki, Robin G Walters, Bong-Jo Kim, Karen L Mohlke, Xueling S Sim
Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature 582 (7811) (2020)
Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes. Expert review of endocrinology & metabolism 15 (3) (2020)
Christopher Wai Kei Lam, Paul Chan, Yuzhen Zhang, Zhongmin Liu, Christopher Wai Kei Lam
Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert opinion on drug metabolism & toxicology 16 (5) (2020)
Chen-Hsiu Lin, Li Shao, Yu-Mei Zhang, Yu-Ju Tu, Yuzhen Zhang, Christopher Wai Kei Lam, Paul Chan, Zhongmin Liu
An evaluation of liraglutide including its efficacy and safety for the treatment of obesity. Expert opinion on pharmacotherapy 21 (3) (2019)
Ya-Bin Ma, Paul Chan, Yuzhen Zhang, Christopher Wai Kei Lam, Zhongmin Liu
Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia. Expert opinion on pharmacotherapy 20 (8) (2019)
Elaine Y K Chow, Emily Wm Poon, Benny Sp Fok, Juliana Chung Ngor Chan, Christopher Wai Kei Lam
CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. Pharmacogenomics and personalized medicine 12 (2019)
June W Y Choon, David B C Wu, H Y Chong, William T L Lo, Catherine S Y Chong, W S Chung, Eileena M C Chui, Christopher Wai Kei Lam, Vivian W Y Lee, S C Lee, Kenneth Kwing-Chin Lee
Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong. Journal of medical economics 22 (3) (2019)
Paul Chan, Li Shao, Christopher Wai Kei Lam, Yuzhen Zhang, Zhong-Min Liu
An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert opinion on pharmacotherapy 20 (1) (2018)
Paul Chan, Li Shao, Christopher Wai Kei Lam, Yuzhen Zhang, Zhong-Min Liu
Metformin transporter pharmacogenomics: insights into drug disposition-where are we now? Expert opinion on drug metabolism & toxicology 14 (11) (2018)
Li Shao, Paul Chan, Christopher Wai Kei Lam, Yuzhen Zhang, Zhong-Min Liu
Single-pill combinations for hypertension: first line treatment for all? Current medical research and opinion 35 (1) (2018)

Christopher Wai Kei Lam.css-eqlu8i{font-size:small;padding-left:4px;} (Brian Tomlinson)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher Wai Kei Lam (Brian Tomlinson)